BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 30259648)

  • 1. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
    Ma J; Li R; Wang J
    Mol Med Rep; 2019 Jul; 20(1):622-632. PubMed ID: 31180552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma.
    Liu G; Zheng J; Zhuang L; Lv Y; Zhu G; Pi L; Wang J; Chen C; Li Z; Liu J; Chen L; Cai G; Zhang X
    Sci Rep; 2018 Oct; 8(1):15250. PubMed ID: 30323196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
    Ren H; Li H; Li P; Xu Y; Liu G; Sun L
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32500914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Hu Y; Guo G; Li J; Chen J; Tan P
    Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy.
    Schmidt S; Linge A; Zwanenburg A; Leger S; Lohaus F; Krenn C; Appold S; Gudziol V; Nowak A; von Neubeck C; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Baumann M; Krause M; Löck S;
    Clin Cancer Res; 2018 Mar; 24(6):1364-1374. PubMed ID: 29298797
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
    Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
    Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
    Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
    Shen S; Bai J; Wei Y; Wang G; Li Q; Zhang R; Duan W; Yang S; Du M; Zhao Y; Christiani DC; Chen F
    Oncol Rep; 2017 Dec; 38(6):3403-3411. PubMed ID: 29130107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.